PG Earnings: Procter & Gamble Stock Up on Q4 Beats
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 29 2025
0mins
Source: TipRanks
Earnings Report Highlights: Procter & Gamble's Fiscal Q4 2025 earnings exceeded expectations with core EPS of $1.48 and revenue of $20.9 billion, attributed to higher pricing and favorable mix impacts.
Leadership Change and Future Guidance: The company anticipates core EPS for Fiscal 2026 between $6.83 and $7.09, while announcing COO Shailesh Jejurikar will succeed CEO Jon Moeller on January 1, 2026.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PG
Wall Street analysts forecast PG stock price to rise
17 Analyst Rating
10 Buy
7 Hold
0 Sell
Moderate Buy
Current: 149.310
Low
150.00
Averages
164.50
High
180.00
Current: 149.310
Low
150.00
Averages
164.50
High
180.00
About PG
The Procter & Gamble Company is focused on providing branded consumer packaged goods to consumers across the world. The Company’s segments include Beauty, Grooming, Health Care, Fabric & Home Care and Baby, Feminine & Family Care. The Company’s products are sold in approximately 180 countries and territories primarily through mass merchandisers, e-commerce, including social commerce channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. It also sells direct to individual consumers. It has operations in approximately 70 countries. It offers products under brands, such as Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Ariel, Downy, Gain, Tide, Always, Always Discreet, Tampax, Bounty and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Febreze Launches New Campaign with MLS Partnership
- Campaign Launch: Febreze announced its partnership with MLS to introduce the “Can’t Wash This” campaign, targeting odor issues on soccer gear and soft surfaces, with an expected influx of 47 million new fans, enhancing brand visibility.
- Celebrity Endorsement: Trevor Noah filmed content inside the Red Bulls New York boot room, adding authenticity to the campaign and emphasizing Febreze's integral role in soccer culture, thereby strengthening emotional connections with the target audience.
- Interactive Experience: The Febreze Boot Room Tour is a 40x40-foot traveling activation featuring five interactive stations that demonstrate how Febreze Fabric freshens hard-to-wash fabrics, enhancing consumer engagement and brand recognition.
- Market Promotion: The campaign will be promoted at various MLS matches, including LA Galaxy and FC Cincinnati games, leveraging live events and social media content to expand brand influence and attract more consumer attention.
See More
Dividend Kings: Steady Growth Investment Choices
- Strong Dividend Growth: Johnson & Johnson has raised its dividend for 64 consecutive years, with a market cap of $624 billion and only 46% of its estimated 2026 earnings allocated for dividends, indicating robust financial health and growth potential.
- Global Beverage Giant: Coca-Cola has also increased its dividend for 64 years, maintaining a stable market cap, with dividends projected to consume 65% of its 2026 earnings, while analysts expect high single-digit earnings growth, ensuring long-term investment value.
- Innovator in Healthcare: Abbott Laboratories has a 54-year streak of dividend increases, focusing on diagnostics, diabetes, and cardiovascular care, with dividends accounting for just 46% of estimated 2026 earnings, and analysts forecasting around 10% annual growth, providing a solid foundation for future development.
- Leader in Household Goods: Procter & Gamble boasts a remarkable 70-year dividend growth record, and despite facing low growth pressures, its dividends represent 63% of estimated 2026 earnings, showcasing its strong competitive position and ability to sustain dividend growth.
See More
Jim Cramer's Trust Adjusts Portfolio with P&G and Honeywell Aerospace
- Procter & Gamble Sale: Jim Cramer's Charitable Trust sold 75 shares of Procter & Gamble at approximately $153.11, reducing its portfolio weighting from 1.45% to 1.15%, strategically taking advantage of the stock's rally to lighten its position.
- Honeywell Aerospace Acquisition: The trust simultaneously purchased 50 shares of Honeywell Aerospace at around $238.53, increasing its weighting from 1.35% to 1.65%, reflecting confidence in the company's potential to create shareholder value as a standalone entity, despite the need for caution regarding short-term price fluctuations.
- Market Dynamics Impact: With Procter & Gamble's stock rising over 2% amid a nearly 3% decline in the tech sector, the effectiveness of Procter as a hedge in the portfolio is evident, particularly during periods of market uncertainty.
- Future Growth Potential: Under new CEO Shailesh Jejurikar, Procter & Gamble has the potential to reinvigorate top-line growth, which could elevate its role beyond merely a hedge, making it a significant asset in the portfolio if performance continues to improve.
See More
Analysis of Retirement Income Growth Strategies
- Income Growth Potential: Starting with a 3.5% yield and assuming an 8% annual growth, a $35,000 income can grow to approximately $140,000 in 20 years, highlighting the critical importance of compounding effects in long-term retirement income.
- High-Yield Risks: High-yield instruments like mortgage REITs may offer substantial initial income, but as principal erodes, retirees will face significant purchasing power loss over a 25-year retirement, underscoring the need for stable growth investments.
- Advantages of Dividend Growth: Companies like Johnson & Johnson and Procter & Gamble have consistently raised dividends over the past decade, achieving 175% and 70 years of dividend growth respectively, demonstrating the effectiveness of dividend growth strategies in long-term investing.
- Capital Requirement Analysis: To achieve an annual income of $60,000, a 3.5% yield requires approximately $1.714 million in capital, while a 12% yield only needs $500,000; although high yields seem attractive, stable growth investments may prove more advantageous in the long run.
See More
Rising Medicare Costs and Investment Strategies
- Rising Medicare Costs: The standard monthly premium for Medicare Part B in 2026 is set at $202.90, reflecting a $17.90 increase from 2025, leading to an annual cost nearing $5,000, which continues to exert financial pressure on retirees.
- Investment Requirement Analysis: To cover the annual $5,000 healthcare bill, investors need approximately $143,000 in capital at a 3.5% yield or about $100,000 at a 5% yield, highlighting the urgent need for stable income sources in retirement planning.
- Yield Comparison: An investment portfolio yielding 3.5% can grow a $5,000 income stream to $19,300 over 20 years, while a 10% yield portfolio remains flat at $5,000, underscoring the significance of long-term investment and compounding returns.
- Retirement Income Planning: Retirees should focus on breaking down healthcare costs, ensuring coverage for Medicare expenses first before addressing other expenditures, thereby optimizing financial management and alleviating economic burdens.
See More
Procter & Gamble Shares Rise 2.7% Amid Earnings Anticipation
- Stock Performance: Procter & Gamble (PG) closed at $151.41, up 2.7% from the previous trading session, indicating positive market sentiment ahead of its earnings report, outperforming the Consumer Staples sector's 3.53% gain.
- Earnings Expectations: The company is expected to report an EPS of $1.43 on July 29, 2026, reflecting a 3.38% decline year-over-year, while projected revenue of $21.43 billion represents a 2.58% increase, highlighting challenges in a competitive market environment.
- Analyst Ratings: Currently rated #4 (Sell) by Zacks, Procter & Gamble shows cautious market sentiment regarding its short-term outlook, with a slight 0.26% decline in EPS estimates over the past month, suggesting investors should monitor analyst revisions closely.
- Valuation Analysis: With a forward P/E ratio of 20.88, significantly above the industry average of 18.73, and a PEG ratio of 6.27, the market anticipates strong future earnings growth, despite the Consumer Products - Staples industry ranking in the bottom 16% of Zacks Industry Rankings.
See More
Febreze Launches New Campaign with MLS Partnership
- Campaign Launch: Febreze announced its partnership with MLS to introduce the “Can’t Wash This” campaign, targeting odor issues on soccer gear and soft surfaces, with an expected influx of 47 million new fans, enhancing brand visibility.
- Celebrity Endorsement: Trevor Noah filmed content inside the Red Bulls New York boot room, adding authenticity to the campaign and emphasizing Febreze's integral role in soccer culture, thereby strengthening emotional connections with the target audience.
- Interactive Experience: The Febreze Boot Room Tour is a 40x40-foot traveling activation featuring five interactive stations that demonstrate how Febreze Fabric freshens hard-to-wash fabrics, enhancing consumer engagement and brand recognition.
- Market Promotion: The campaign will be promoted at various MLS matches, including LA Galaxy and FC Cincinnati games, leveraging live events and social media content to expand brand influence and attract more consumer attention.
See More
Dividend Kings: Steady Growth Investment Choices
- Strong Dividend Growth: Johnson & Johnson has raised its dividend for 64 consecutive years, with a market cap of $624 billion and only 46% of its estimated 2026 earnings allocated for dividends, indicating robust financial health and growth potential.
- Global Beverage Giant: Coca-Cola has also increased its dividend for 64 years, maintaining a stable market cap, with dividends projected to consume 65% of its 2026 earnings, while analysts expect high single-digit earnings growth, ensuring long-term investment value.
- Innovator in Healthcare: Abbott Laboratories has a 54-year streak of dividend increases, focusing on diagnostics, diabetes, and cardiovascular care, with dividends accounting for just 46% of estimated 2026 earnings, and analysts forecasting around 10% annual growth, providing a solid foundation for future development.
- Leader in Household Goods: Procter & Gamble boasts a remarkable 70-year dividend growth record, and despite facing low growth pressures, its dividends represent 63% of estimated 2026 earnings, showcasing its strong competitive position and ability to sustain dividend growth.
See More
Jim Cramer's Trust Adjusts Portfolio with P&G and Honeywell Aerospace
- Procter & Gamble Sale: Jim Cramer's Charitable Trust sold 75 shares of Procter & Gamble at approximately $153.11, reducing its portfolio weighting from 1.45% to 1.15%, strategically taking advantage of the stock's rally to lighten its position.
- Honeywell Aerospace Acquisition: The trust simultaneously purchased 50 shares of Honeywell Aerospace at around $238.53, increasing its weighting from 1.35% to 1.65%, reflecting confidence in the company's potential to create shareholder value as a standalone entity, despite the need for caution regarding short-term price fluctuations.
- Market Dynamics Impact: With Procter & Gamble's stock rising over 2% amid a nearly 3% decline in the tech sector, the effectiveness of Procter as a hedge in the portfolio is evident, particularly during periods of market uncertainty.
- Future Growth Potential: Under new CEO Shailesh Jejurikar, Procter & Gamble has the potential to reinvigorate top-line growth, which could elevate its role beyond merely a hedge, making it a significant asset in the portfolio if performance continues to improve.
See More
Analysis of Retirement Income Growth Strategies
- Income Growth Potential: Starting with a 3.5% yield and assuming an 8% annual growth, a $35,000 income can grow to approximately $140,000 in 20 years, highlighting the critical importance of compounding effects in long-term retirement income.
- High-Yield Risks: High-yield instruments like mortgage REITs may offer substantial initial income, but as principal erodes, retirees will face significant purchasing power loss over a 25-year retirement, underscoring the need for stable growth investments.
- Advantages of Dividend Growth: Companies like Johnson & Johnson and Procter & Gamble have consistently raised dividends over the past decade, achieving 175% and 70 years of dividend growth respectively, demonstrating the effectiveness of dividend growth strategies in long-term investing.
- Capital Requirement Analysis: To achieve an annual income of $60,000, a 3.5% yield requires approximately $1.714 million in capital, while a 12% yield only needs $500,000; although high yields seem attractive, stable growth investments may prove more advantageous in the long run.
See More
Rising Medicare Costs and Investment Strategies
- Rising Medicare Costs: The standard monthly premium for Medicare Part B in 2026 is set at $202.90, reflecting a $17.90 increase from 2025, leading to an annual cost nearing $5,000, which continues to exert financial pressure on retirees.
- Investment Requirement Analysis: To cover the annual $5,000 healthcare bill, investors need approximately $143,000 in capital at a 3.5% yield or about $100,000 at a 5% yield, highlighting the urgent need for stable income sources in retirement planning.
- Yield Comparison: An investment portfolio yielding 3.5% can grow a $5,000 income stream to $19,300 over 20 years, while a 10% yield portfolio remains flat at $5,000, underscoring the significance of long-term investment and compounding returns.
- Retirement Income Planning: Retirees should focus on breaking down healthcare costs, ensuring coverage for Medicare expenses first before addressing other expenditures, thereby optimizing financial management and alleviating economic burdens.
See More
Procter & Gamble Shares Rise 2.7% Amid Earnings Anticipation
- Stock Performance: Procter & Gamble (PG) closed at $151.41, up 2.7% from the previous trading session, indicating positive market sentiment ahead of its earnings report, outperforming the Consumer Staples sector's 3.53% gain.
- Earnings Expectations: The company is expected to report an EPS of $1.43 on July 29, 2026, reflecting a 3.38% decline year-over-year, while projected revenue of $21.43 billion represents a 2.58% increase, highlighting challenges in a competitive market environment.
- Analyst Ratings: Currently rated #4 (Sell) by Zacks, Procter & Gamble shows cautious market sentiment regarding its short-term outlook, with a slight 0.26% decline in EPS estimates over the past month, suggesting investors should monitor analyst revisions closely.
- Valuation Analysis: With a forward P/E ratio of 20.88, significantly above the industry average of 18.73, and a PEG ratio of 6.27, the market anticipates strong future earnings growth, despite the Consumer Products - Staples industry ranking in the bottom 16% of Zacks Industry Rankings.
See More
